Blebbishield应急程序：细胞转化的凋亡途径。 - Suppr

Suppr

超能文献

Blebbishield emergency program: an apoptotic route to cellular transformation.

作者信息

Jinesh G G, Kamat A M

机构信息

Department of Urology, Unit 1373, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Cell Death Differ. 2016 May;23(5):757-8. doi: 10.1038/cdd.2016.26. Epub 2016 Mar 11.

DOI:10.1038/cdd.2016.26

PMID:26967969

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4832111/

Abstract

摘要

相似文献

Blebbishield emergency program: an apoptotic route to cellular transformation.Blebbishield应急程序：细胞转化的凋亡途径。

Cell Death Differ. 2016 May;23(5):757-8. doi: 10.1038/cdd.2016.26. Epub 2016 Mar 11.

The Blebbishield Emergency Program Overrides Chromosomal Instability and Phagocytosis Checkpoints in Cancer Stem Cells.Blebbishield 紧急计划会绕过癌症干细胞中的染色体不稳定性和吞噬作用检查点。

Cancer Res. 2017 Nov 15;77(22):6144-6156. doi: 10.1158/0008-5472.CAN-17-0522. Epub 2017 Aug 30.

CFDODA-Me induces apoptosis, degrades Sp1, and blocks the transformation phase of the blebbishield emergency program.CFDODA-Me诱导细胞凋亡，降解Sp1，并阻断气泡护盾应急程序的转化阶段。

Apoptosis. 2017 May;22(5):719-729. doi: 10.1007/s10495-017-1359-1.

Mitochondrial oligomers boost glycolysis in cancer stem cells to facilitate blebbishield-mediated transformation after apoptosis.线粒体寡聚体增强癌症干细胞中的糖酵解，以促进凋亡后肌动蛋白防护介导的转化。

Cell Death Discov. 2016 Feb 1;2:16003. doi: 10.1038/cddiscovery.2016.3. eCollection 2016.

Implications of apoptosis regulators in tumorigenesis.凋亡调节因子在肿瘤发生中的意义。

Cancer Metastasis Rev. 2004 Aug-Dec;23(3-4):367-87. doi: 10.1023/B:CANC.0000031774.32572.df.

Regulation of cell death in oncogenesis.

Cancer Res. 2005 Sep 15;65(18):8069-71. doi: 10.1158/0008-5472.CAN-05-2439.

Novel PKC-ζ to p47 phox interaction is necessary for transformation from blebbishields.新型蛋白激酶C-ζ与p47吞噬细胞氧化酶相互作用是从肌动蛋白小体转变所必需的。

Sci Rep. 2016 Apr 4;6:23965. doi: 10.1038/srep23965.

[Cellular biology of human cancers as a basis for seeking tumor markers].[作为寻找肿瘤标志物基础的人类癌症细胞生物学]

Verh Dtsch Ges Inn Med. 1991;97:403-5.

[Studies of growth, differentiation and neoplastic transformation of human and animal cells--views and trends:1985-1988].[人和动物细胞的生长、分化及肿瘤转化研究——观点与趋势：1985 - 1988年]

Postepy Biochem. 1988;34(4):269-71.

NF-kappaB in solid tumors.实体瘤中的核因子κB

Biochem Pharmacol. 2006 Oct 30;72(9):1142-52. doi: 10.1016/j.bcp.2006.07.032. Epub 2006 Sep 7.

引用本文的文献

Beyond Death: Unmasking the Intricacies of Apoptosis Escape.超越死亡：揭开细胞凋亡逃逸的复杂性。

Mol Diagn Ther. 2024 Jul;28(4):403-423. doi: 10.1007/s40291-024-00718-w. Epub 2024 Jun 18.

Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer.纳米技术在逆转结直肠癌治疗抵抗和控制转移中的应用。

World J Gastroenterol. 2023 Apr 7;29(13):1911-1941. doi: 10.3748/wjg.v29.i13.1911.

Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis.经典的上皮-间充质转化 (EMT) 和替代性细胞死亡过程驱动的肿瘤转移的 blebbishield 转移性女巫 (BMW) 通路。

Signal Transduct Target Ther. 2022 Aug 23;7(1):296. doi: 10.1038/s41392-022-01132-6.

Mutant p53s and chromosome 19 microRNA cluster overexpression regulate cancer testis antigen expression and cellular transformation in hepatocellular carcinoma.突变型 p53 和 19 号染色体微小 RNA 簇过表达调节肝癌中癌睾丸抗原的表达和细胞转化。

Sci Rep. 2021 Jun 16;11(1):12673. doi: 10.1038/s41598-021-91924-7.

Targeting K-Ras and apoptosis-driven cellular transformation in cancer.靶向癌症中K-Ras和凋亡驱动的细胞转化

Cell Death Discov. 2021 Apr 14;7(1):80. doi: 10.1038/s41420-021-00457-5.

Regulation of MYO18B mRNA by a network of C19MC miRNA-520G, IFN-γ, CEBPB, p53 and bFGF in hepatocellular carcinoma.C19MC miRNA-520G、IFN-γ、CEBPB、p53 和 bFGF 调控网络对肝癌中 MYO18B mRNA 的调控。

Sci Rep. 2020 Jul 23;10(1):12371. doi: 10.1038/s41598-020-69179-5.

Cancer Stem Cells: Emergent Nature of Tumor Emergency.癌症干细胞：肿瘤急症的新特性

Front Genet. 2018 Nov 16;9:544. doi: 10.3389/fgene.2018.00544. eCollection 2018.

Chromosome 19 miRNA cluster and CEBPB expression specifically mark and potentially drive triple negative breast cancers.19 号染色体 miRNA 簇和 CEBPB 表达特异性标记并可能驱动三阴性乳腺癌。

PLoS One. 2018 Oct 18;13(10):e0206008. doi: 10.1371/journal.pone.0206008. eCollection 2018.

Apoptosis: A Target for Anticancer Therapy.细胞凋亡：抗癌治疗的新靶点。

Int J Mol Sci. 2018 Feb 2;19(2):448. doi: 10.3390/ijms19020448.

Molecular genetics and cellular events of K-Ras-driven tumorigenesis.K-Ras 驱动的肿瘤发生的分子遗传学和细胞事件。

Oncogene. 2018 Feb 15;37(7):839-846. doi: 10.1038/onc.2017.377. Epub 2017 Oct 23.

本文引用的文献

Cell Death Discov. 2016 Feb 1;2:16003. doi: 10.1038/cddiscovery.2016.3. eCollection 2016.

Endocytosis and serpentine filopodia drive blebbishield-mediated resurrection of apoptotic cancer stem cells.内吞作用和蛇形丝状伪足驱动气泡护盾介导的凋亡癌干细胞复活。

Cell Death Discov. 2016;2:15069-. doi: 10.1038/cddiscovery.2015.69. Epub 2016 Jan 25.

Smac mimetic with TNF-α targets Pim-1 isoforms and reactive oxygen species production to abrogate transformation from blebbishields.与肿瘤坏死因子-α作用的Smac模拟物靶向Pim-1亚型和活性氧生成，以消除来自肌动蛋白小体的转化。

Biochem J. 2016 Jan 1;473(1):99-107. doi: 10.1042/BJ20150877. Epub 2015 Oct 27.

Bladder cancer stem cells: biological and therapeutic perspectives.膀胱癌干细胞：生物学与治疗前景

Curr Stem Cell Res Ther. 2014 Mar;9(2):89-101. doi: 10.2174/1574888x08666131113123051.

Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis.凋亡孔的组成元件：Bax和Bak在凋亡过程中如何被激活并寡聚化。

Cell Death Differ. 2014 Feb;21(2):196-205. doi: 10.1038/cdd.2013.139. Epub 2013 Oct 25.

Blebbishields, the emergency program for cancer stem cells: sphere formation and tumorigenesis after apoptosis.Blebbishields，癌症干细胞的应急方案：细胞凋亡后球体形成和肿瘤发生。

Cell Death Differ. 2013 Mar;20(3):382-95. doi: 10.1038/cdd.2012.140. Epub 2012 Nov 23.

Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism.致癌性 Kras 通过调节合成代谢葡萄糖代谢维持胰腺肿瘤。

Cell. 2012 Apr 27;149(3):656-70. doi: 10.1016/j.cell.2012.01.058.

Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL.模拟 Smac 使 BCG 刺激的中性粒细胞通过 TNF-α发挥抗癌作用，但不通过 TRAIL 和 FasL。

J Leukoc Biol. 2012 Jul;92(1):233-44. doi: 10.1189/jlb.1211623. Epub 2012 Apr 18.

Secondary necrosis: the natural outcome of the complete apoptotic program.继发坏死：完全凋亡程序的自然结果。

FEBS Lett. 2010 Nov 19;584(22):4491-9. doi: 10.1016/j.febslet.2010.10.046. Epub 2010 Oct 26.

Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site.Pim-1激酶通过在促凋亡蛋白Bad的Ser112守门位点使其磷酸化，促进其失活。

FEBS Lett. 2004 Jul 30;571(1-3):43-9. doi: 10.1016/j.febslet.2004.06.050.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验